Pharming Group N.V. Noncurrent Financial Assets At Fair Value Through Profit Or Loss
Pharming Group N.V. (PHAR) had Noncurrent Financial Assets At Fair Value Through Profit Or Loss of $6.70 million as of 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss · last filed 2026-04-02
- 2025-12-31: Noncurrent Financial Assets At Fair Value Through Profit Or Loss $6.70M.
- 2024-12-31: Noncurrent Financial Assets At Fair Value Through Profit Or Loss $3.77M.
- 2023-12-31: Noncurrent Financial Assets At Fair Value Through Profit Or Loss $6.09M.
- 2022-12-31: Noncurrent Financial Assets At Fair Value Through Profit Or Loss $6.83M.
| Period end | Noncurrent Financial Assets At Fair Value Through Profit Or Loss |
|---|---|
| 2025-12-31 | $6.70M 20-F · filed 2026-04-02 |
| 2024-12-31 | $3.77M 20-F · filed 2026-04-02 |
| 2023-12-31 | $6.09M 20-F · filed 2025-04-03 |
| 2022-12-31 | $6.83M 20-F · filed 2024-04-04 |
| 2021-12-31 | $0.00 20-F · filed 2023-04-05 |